Healthcare
Siemens Healthineers Hits New Low as Spin-Off Timeline Firms Up and China Headwinds Deepen
Siemens Healthineers shares slumped to a fresh 52-week trough on Friday, touching €35.29, as the medical technology group prepares to...
BioNTech’s Cancer Pipeline Steals the Show as COVID Vaccine Woes Mount
The narrative around BioNTech is undergoing a quiet but decisive shift. While the Mainz-based biotech’s legacy COVID-19 vaccine business sputters,...
Novo Nordisk’s Washington Shuffle and Teen Pill Progress Mask a Grim Market Reality
The Danish drugmaker is fighting on multiple fronts — and losing ground on most of them. While Novo Nordisk celebrates...
BioNTech’s ADC Breakthrough Fuels Rally as Oncology Pivot Gathers Pace
The numbers tell a stark story of transition. BioNTech’s Covid vaccine revenue is sliding toward a projected €2.0-2.3 billion for...
Siemens Healthineers Pins Hopes on AI and Spin-Off as Tariffs and China Headwinds Bite
The gap between Siemens Healthineers’ strategic ambitions and its stock market performance has rarely been wider. While the medical technology...
Hims & Hers Faces a Squeeze on Two Fronts: Margins Shrink as Amazon Looms
The telehealth operator Hims & Hers is navigating one of its most turbulent periods yet, caught between a costly strategic...
ImmunityBio’s Saudi Launch and Record Sales Collide With Shareholder Litigation
ImmunityBio has pulled off a remarkable feat in the Middle East, getting its immunotherapy ANKTIVA onto the Saudi Arabian market...
Siemens Healthineers Hires a Google Alum as Tariffs and Debt Cloud the Outlook
Siemens Healthineers made a splash at Berlin’s DMEA healthcare conference this week, unveiling an ambitious artificial-intelligence strategy and a high-profile...
Siemens Engineers a Two-Track Strategy: Chipmaking AI Deals and a Slow-Burn Healthineers Exit
Siemens is threading a needle between high-tech expansion and corporate simplification, laying out fresh details on both its deepening ties...
Redcare Pharmacy’s Tech-Driven Turnaround Faces a Margin Reality Check
Redcare Pharmacy's stock has clawed back from a March low of 31 euros, now trading around 53 euros, yet it...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
